
Chapter 45 DIABETES MELLITUS314
12. What occurs pathophysiologically to cause HHS?
HHS usually occurs in older, Type II diabetics. The pathophysiology is the same as DKA,
without the generation of ketones. In the absence of insulin, cellular receptors are unable to
transport glucose intracellularly, creating an osmotic gradient. Extracellular volume expands at
the expense of intracellular dehydration. Elevated glucose levels overcome renal filtration, and
glucosuria results, causing osmotic diuresis and profound dehydration. Why these patients
are not ketotic remains controversial. One likely factor is slightly more available levels of
insulin in HHS than DKA, inhibiting lipolysis. A poorly understood aspect of HHS pathogenesis
is the lower levels of catabolic hormones found in HHS patients compared to their DKA
counterparts.
13. What are the precipitants of HHS?
Any illness leading to dehydration is a risk factor for HHS in the Type II diabetic. Comorbid
conditions, such as renal disease and heart failure, complicate HHS. Causes include infections,
primarily pneumonia and urinary tract infections (UTIs), stroke, intracranial hemorrhage,
myocardial infarction, and pulmonary embolism. Drugs are frequently implicated including:
diuretics, b-blockers, histamine-2 blockers, antipsychotics, alcohol, cocaine, and total
parenteral nutrition (TPN).
14. What are the four key points in ED management of patients with HHS?
n
Fluid administration: 1 to 2 L of normal saline should be administered initially. Fluid
deficits may be as high as 10 L, however, judicious rehydration should be observed in
cardiac and renal patients. Be aware of correcting hypernatremia too quickly.
n
Potassium: Potassium should be repleted at 10 to 20 mEq/h in patients with normal renal
function.
n
Insulin: Although most patients with HHS do not receive insulin therapy, patients with
acidosis, hyperkalemia, or renal failure need insulin to lower glucose levels and resolve
metabolic derangements. A starting dose of 0.15 U/kg of insulin given intravenously, with
an infusion rate of 0.1 U/kg/h, is reasonable in these patients.
n
Glucose: Add to IV fluids when levels are less than 250 mg/dL.
15. Which patients with HHS should be admitted to the hospital?
All patients with HHS should be admitted. Most require at least 24 hours of monitoring for
treatment of electrolyte abnormalities, fluid administration, and evaluation of precipitating
causes.
16. Define hypoglycemia.
Serum glucose ,50 mg/dL.
17. Who develops hypoglycemia?
Patients who are taking hypoglycemic medications are at greatest risk for hypoglycemia.
Other causes include accidental or intentional overdose of insulin, pentamidine, aspirin,
haloperidol, insulinomas, renal failure, sepsis, adrenal insufficiency, sepsis, alcoholism, or
heart failure.
18. Which overdoses of oral hypoglycemic agents do not cause hypoglycemia?
n
Metformin overdose does not cause hypoglycemia because it decreases hepatic production
of glucose and increases insulin sensitivity. Instead, symptoms of overdose include nausea,
vomiting, and abdominal pain. Lactic acidosis is a known complication of therapeutic and
supratherapeutic doses of metformin. Lactic acidosis may be treated with sodium
bicarbonate or hemodialysis.
n
Thiazolidinediones increase peripheral tissue glucose use and do not cause hypoglycemia.
Hepatoxicity has been reported with these drugs.
n
a-glucosidase inhibitors decrease gastrointestinal glucose absorption and do not cause
hypoglycemia. Symptoms of overdose include bloating, abdominal pain, and diarrhea.